Connection

Fabiano Di Marco to Adrenergic beta-2 Receptor Agonists

This is a "connection" page, showing publications Fabiano Di Marco has written about Adrenergic beta-2 Receptor Agonists.
  1. Early management of COPD: where are we now and where do we go from here? A Delphi consensus project. Int J Chron Obstruct Pulmon Dis. 2019; 14:353-360.
    View in: PubMed
    Score: 0.655
  2. Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study. NPJ Prim Care Respir Med. 2017 Sep 07; 27(1):51.
    View in: PubMed
    Score: 0.594
  3. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Respir Med. 2017 04; 125:49-56.
    View in: PubMed
    Score: 0.573
  4. LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018; 13:3115-3130.
    View in: PubMed
    Score: 0.160
  5. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine. COPD. 2017 Dec; 14(6):641-647.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.